• Mashup Score: 0
    FDA Approves First Gene Therapy for Hemophilia B - 2 year(s) ago

    94% of hemophilia B patients given the gene therapy no longer require  prophylactic infusions of Factor IX.

    Source: CheckRare
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CheckRare
      CheckRare

      The U.S. Food and Drug Administration has approved etranacogene dezaparvovec (Hemgenix) for treating adults with Hemophilia B. https://t.co/HhWtGn7mYR @US_FDA @FDAMedWatch @FDA_Drug_Info @uniQure_NV @CSLBehring @NHF_Hemophilia #raredisease #FDA #HemophiliaB #FDADrugApproval

  • Mashup Score: 0
    FDA Approves First Gene Therapy for Hemophilia B - 2 year(s) ago

    94% of hemophilia B patients given the gene therapy no longer require  prophylactic infusions of Factor IX.

    Source: CheckRare
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CheckRare
      CheckRare

      The U.S. Food and Drug Administration has approved etranacogene dezaparvovec (Hemgenix) for treating adults with Hemophilia B. https://t.co/HhWtGn7UOp @US_FDA @FDAMedWatch @FDA_Drug_Info @uniQure_NV @CSLBehring @NHF_Hemophilia #raredisease #FDA #HemophiliaB #FDADrugApproval